Cargando…
Enhancing CAR T function with the engineered secretion of C. perfringens neuraminidase
Prior to adoptive transfer, CAR T cells are activated, lentivirally infected with CAR transgenes, and expanded over 9 to 11 days. An unintended consequence of this process is the progressive differentiation of CAR T cells over time in culture. Differentiated T cells engraft poorly, which limits thei...
Autores principales: | Durgin, Joseph S., Thokala, Radhika, Johnson, Lexus, Song, Edward, Leferovich, John, Bhoj, Vijay, Ghassemi, Saba, Milone, Michael, Binder, Zev, O'Rourke, Donald M., O'Connor, Roddy S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899523/ https://www.ncbi.nlm.nih.gov/pubmed/34813961 http://dx.doi.org/10.1016/j.ymthe.2021.11.014 |
Ejemplares similares
-
Rapid manufacturing of non-activated potent CAR T cells
por: Ghassemi, Saba, et al.
Publicado: (2022) -
CAR T-Cells Depend on the Coupling of NADH Oxidation with ATP Production
por: Garcia-Canaveras, Juan C., et al.
Publicado: (2021) -
Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent Glioblastoma
por: Durgin, Joseph S., et al.
Publicado: (2021) -
High-Affinity Chimeric Antigen Receptor With Cross-Reactive scFv to Clinically Relevant EGFR Oncogenic Isoforms
por: Thokala, Radhika, et al.
Publicado: (2021) -
The IAP antagonist birinapant enhances chimeric antigen receptor T cell therapy for glioblastoma by overcoming antigen heterogeneity
por: Song, Edward Z., et al.
Publicado: (2022)